NASDAQ · ALVO
Alvotech
Healthcare · Drug Manufacturers - Specialty & Generic
$5.85
Down-$0.18 (-3.08%)
Updated Oct 9, 2026, 1:58 AM
SID Score
5.2/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 1.24B
- P/E ratio
- 17.23
- Dividend yield
- 0.00%
- 52-week range
- $2.94 – $9.05
- Volume
- 864.57K
- Avg. volume
- 511.3K
Price performance · ALVO
ALVO price history
1M range · 20 trading sessions · Daily adjusted prices
Prices through Oct 7, 2026
ALVO closed at $5.85 after 20 trading sessions, up 11.64% for the selected period.
- Last close
- $5.85
- Period change
- +11.64%
- Period low
- $5.02
- Period high
- $6.15
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 7, 2026 | $6.10 | $6.14 | $5.845 | $5.85 | 864.57K |
| Oct 6, 2026 | $6.07 | $6.17 | $6.00 | $6.14 | 1.22M |
| Oct 5, 2026 | $5.99 | $6.53 | $5.90 | $6.11 | 2.9M |
| Oct 2, 2026 | $5.61 | $5.70 | $5.43 | $5.45 | 750.93K |
| Oct 1, 2026 | $5.81 | $5.82 | $5.46 | $5.62 | 1.2M |
| Sep 30, 2026 | $5.95 | $5.97 | $5.76 | $5.80 | 1.14M |
| Sep 29, 2026 | $6.135 | $6.17 | $5.825 | $5.92 | 1.17M |
| Sep 28, 2026 | $5.73 | $6.17 | $5.675 | $6.15 | 1.44M |
| Sep 25, 2026 | $5.90 | $5.90 | $5.67 | $5.75 | 705.19K |
| Sep 24, 2026 | $5.75 | $6.06 | $5.75 | $5.88 | 1.2M |
| Sep 23, 2026 | $5.86 | $5.89 | $5.70 | $5.81 | 774.27K |
| Sep 22, 2026 | $5.90 | $5.97 | $5.715 | $5.84 | 978.06K |
| Sep 21, 2026 | $5.92 | $5.98 | $5.74 | $5.88 | 1.31M |
| Sep 18, 2026 | $5.40 | $5.985 | $5.395 | $5.87 | 3.54M |
| Sep 17, 2026 | $5.22 | $5.455 | $5.20 | $5.34 | 1.71M |
| Sep 16, 2026 | $5.40 | $5.53 | $5.10 | $5.10 | 3.87M |
| Sep 15, 2026 | $5.05 | $5.07 | $4.90 | $5.02 | 610.03K |
| Sep 14, 2026 | $5.225 | $5.26 | $5.035 | $5.05 | 674.19K |
| Sep 11, 2026 | $5.28 | $5.39 | $5.26 | $5.29 | 667.87K |
| Sep 10, 2026 | $5.21 | $5.34 | $5.14 | $5.24 | 540.86K |
Latest ALVO news
The latest Smart Investors Daily articles mentioning ALVO.
Stock researchResearch & News · News
Company
Market Activity
Research & News

